BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31857147)

  • 1. Epigallocatechin-3-gallate downregulates PDHA1 interfering the metabolic pathways in human herpesvirus 8 harboring primary effusion lymphoma cells.
    Yeh LC; Shyu HW; Jin YR; Chiou YH; Lin KH; Chou MC; Huang MH; Wang YF
    Toxicol In Vitro; 2020 Jun; 65():104753. PubMed ID: 31857147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells.
    Tsai CY; Chen CY; Chiou YH; Shyu HW; Lin KH; Chou MC; Huang MH; Wang YF
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol induces cell death and inhibits human herpesvirus 8 replication in primary effusion lymphoma cells.
    Tang FY; Chen CY; Shyu HW; Hong S; Chen HM; Chiou YH; Lin KH; Chou MC; Wang LY; Wang YF
    Chem Biol Interact; 2015 Dec; 242():372-9. PubMed ID: 26549478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin disrupts the latency of human herpesvirus 8 and induces apoptosis in primary effusion lymphoma cells.
    Wang YF; Chiou YH; Wang LY; Chang ST; Shyu HW; Chen CY; Lin KH; Chou MC
    Cancer Invest; 2012 May; 30(4):268-74. PubMed ID: 22480174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.
    Manzano M; Patil A; Waldrop A; Dave SS; Behdad A; Gottwein E
    Nat Commun; 2018 Aug; 9(1):3263. PubMed ID: 30111820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
    Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
    Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
    Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
    Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
    Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
    Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
    Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models.
    Wei R; Mao L; Xu P; Zheng X; Hackman RM; Mackenzie GG; Wang Y
    Food Funct; 2018 Nov; 9(11):5682-5696. PubMed ID: 30310905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
    Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracavitary/solid variant of primary effusion lymphoma.
    Kim Y; Leventaki V; Bhaijee F; Jackson CC; Medeiros LJ; Vega F
    Ann Diagn Pathol; 2012 Dec; 16(6):441-6. PubMed ID: 22497739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
    Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
    Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR‑21‑5p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer.
    Liu Z; Yu M; Fei B; Fang X; Ma T; Wang D
    Oncol Rep; 2018 Nov; 40(5):2955-2963. PubMed ID: 30226598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARα activation sensitizes cancer cells to epigallocatechin-3-gallate (EGCG) treatment via suppressing heme oxygenase-1.
    Zhang S; Yang X; Luo J; Ge X; Sun W; Zhu H; Zhang W; Cao J; Hou Y
    Nutr Cancer; 2014; 66(2):315-24. PubMed ID: 24447094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
    Mayr C; Wagner A; Neureiter D; Pichler M; Jakab M; Illig R; Berr F; Kiesslich T
    BMC Complement Altern Med; 2015 Jun; 15():194. PubMed ID: 26100134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.
    Yang D; Chen W; Xiong J; Sherrod CJ; Henry DH; Dittmer DP
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4762-8. PubMed ID: 25341731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.